The ORlistat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORliCARDIA) studyTriantafyllos Didangelos, Dimitrios T. Karamitsos, Stavros Bousboulas et al.|Current Medical Research and Opinion|2004Cited by 70